ERBB2 and neoplasm: Our multinomial logistic regression results showed that a decrease in TTP would lead to a rise in the odds of breast cancer with positive lymph node metastasis, higher tumor grade, larger tumor size, hormone receptor negativity, HER2 positivity, or higher Ki67 level.